Isconova
Uppsala, Uppsala Lan, Sweden
About Isconova
Isconova AB is an R&D company that develops and commercializes adjuvants and vaccines. It provides adjuvants for veterinary and human vaccines for an enhanced immune reaction with a longer duration. The products of the company include Matrix-M, which is a cell-mediated and antibody-mediated immune response for use in vaccines for humans, dogs, and cats. Matrix-C vaccines are used for horses, and Matrix-Q vaccines are used for cows and fish. Matrix-F is also used for fish. It also offers AbISCO research reagents, including AbISCO-100, for use in saponin-sensitive animal species, such as mice.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2008)
- Website: isconova.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/isconova-2503973 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.